Palantir Just Hit $300 Billion. The Numbers Say That’s Only the Start.

Photo of Chris MacDonald
By Chris MacDonald Published

Quick Read

  • PLTR's U.S. commercial revenue surged 133% while adjusted operating margins expanded to 60%, forcing a full-year guidance raise to $7.65 billion.

  • PLTR's 145% Rule of 40 score puts it in company Alex Karp claims only NVDA and MU occupy.

  • PLTR shares dropped 27% year to date but exploded 21% higher in one week, with prediction markets now pricing $138 as likely by July.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Palantir didn't make the cut. Grab the names FREE today.

Palantir Just Hit $300 Billion. The Numbers Say That’s Only the Start.

© AndreyKrav / iStock Editorial via Getty Images

Palantir Technologies (NASDAQ:PLTR | PLTR Price Prediction) now carries a market capitalization of a little more than $300 billion as of July 3, 2026, which has taken many investors on a nice ride, given the company’s the software-with-a-defense-flavor story. Palantir is now arguing for a seat inside the mega-cap conversation, alongside the AI infrastructure names its own CEO likes to invoke.

What It Means

A valuation this size implies specific operational realities, and Palantir’s Q1 2026 filing supplies them. Revenue reached $1.632 billion this past quarter, growing nearly 85% year over year. That’s the highest reported growth rate in the company’s history as a public company. Additionally, the engine of the company (U.S. revenue) climbed 104% year over year to $1.282 billion, crossing 100% growth for the first time since the direct listing. U.S. commercial revenue rose 133% year over year to $595 million.

It’s not only a revenue story. In fact, Palantir’s profitability has closely correlated with its revenue growth. This past quarter, GAAP operating income landed at $754 million, up 328.29% from a year earlier, with the company posting a 46% operating margin. Adjusted operating margin expanded to 60% from 44% a year earlier, and free cash flow reached $924.63 million, up 204.08%. The Rule of 40 score hit 145%, a level the CEO framed as company territory shared only with NVIDIA (NASDAQ:NVDA), Micron (NASDAQ:MU) and SK hynix.

As a result of these numbers, Palantir raised its guidance considerably. The company now guides for full-year 2026 revenue between $7.650 billion to $7.662 billion, which amounts to roughly 71% year over year growth. That’s impressive, because this is 10 percentage points above the prior quarter’s outlook. U.S. commercial guidance is in excess of $3.224 billion, calling for at least 120% growth.

Market Reaction

The stock has not tracked the fundamentals in a straight line. PLTR closed at $129.30 on July 2, 2026, versus $177.75 to start the year, a 27.26% year to date decline. The stock’s one-month change is -15.03%, so clearly momentum has flipped hard in the last week. That said, over five years, Palantir stock is still up 429.05%.

Bull Case

The case for long-term holders leans on three facts, all in the filing. First, the business is doubling in the U.S. with expanding, not compressing, margins. Growth of 104% year over year in the U.S. paired with a 60% adjusted operating margin is the profile investors typically pay up to own.

Second, the backlog validates the growth rate. Total remaining deal value reached $11.8 billion, up 98% year over year. Remaining performance obligations climbed to $4.5 billion, up 134% year over year, with net dollar retention hit 150%. This was driven by the fact that Palantir closed 206 deals of $1 million or more and 47 deals of $10 million or more in the quarter.

Third, cash generation is real and rising. Operating cash flow reached $899.17 million in the quarter, and the balance sheet holds $8 billion in cash, equivalents, and short-term U.S. Treasuries. As CEO Alex Karp put it on the Q1 call, “Our free cash flow this quarter is larger than our revenue a year ago in the same quarter.” Full-year adjusted free cash flow guidance is $4.2 billion to $4.4 billion.

Prediction market participants have started to reflect the shift. Polymarket assigns a 70.5% probability to PLTR hitting $138 in July, with 47.5% for $144 and 32.5% for $150. Sub-$100 outcomes carry 10.5% or less.

Bottom Line

For retirement-focused holders, the story is the combination of an 84.71% growth rate, a 60% adjusted operating margin, and a raised full-year outlook calling for 71% growth, layered onto a $296.88 billion market cap.

Certainly, Palantir’s valuation remains rich, with a forward P/E near 80 and a price to sales ratio of 53.54, and the filing lists real risks. Those can best be described as long sales cycles, contracts terminable for convenience, and $201.6 million in quarterly stock-based compensation.

The next test is the company’s upcoming Q2 2026 report, where management has guided revenue of $1.797 billion to $1.801 billion. If Palantir’s U.S. commercial engine holds triple-digit growth into a second consecutive quarter, the $100 billion narrative stops being a narrative.

Contact [email protected] for any questions or corrections.

Photo of Chris MacDonald
About the Author Chris MacDonald →

Chris MacDonald is a 24/7 Wall St. contributor and long-time contributor to other notable finance publications, including The Motley Fool and InvestorPlace. With an MBA in Finance, and more than a decade of experience in venture capital and the corporate finance world, Chris brings a long-term perspective to his analysis of equities and alternative assets.

His love of investing and focus on finding quality undervalued stocks is complemented by recent research into alternative assets as well. He takes a long-term approach to analyzing companies and cryptos, with a focus on directing the reader to the most sustainable and important catalysts for each respective potential investment.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

AKAM Vol: 7,022,794
ANET Vol: 11,863,498
SMCI Vol: 36,738,684
VLO Vol: 3,867,564
BKR Vol: 16,351,350

Top Losing Stocks

SYF Vol: 9,339,387
CTRA Vol: 73,319,495
MRNA Vol: 6,542,061
AXON Vol: 1,153,266
RMD Vol: 1,733,114